Key findings from the UKCCMP cohort of 877 patients with haematological malignancy and COVID‐19: disease control as an important factor relative to recent chemotherapy or anti‐CD20 therapy

Patients with haematological malignancies have a high risk of severe infection and death from SARS‐CoV‐2. In this prospective observational study, we investigated the impact of cancer type, disease activity, and treatment in 877 unvaccinated UK patients with SARS‐CoV‐2 infection and active haematolo...

Descripción completa

Detalles Bibliográficos
Autores principales: Booth, Stephen, Curley, Helen M., Varnai, Csilla, Arnold, Roland, Lee, Lennard Y. W., Campton, Naomi A., Cook, Gordon, Purshouse, Karin, Aries, James, Innes, Andrew, Cook, Lucy B., Tomkins, Oliver, Oram, Helen S., Tilby, Michael, Kulasekararaj, Austin, Wrench, David, Dolly, Saoirse, Newsom‐Davies, Tom, Pettengell, Ruth, Gault, Abigail, Moody, Sam, Mittal, Sajjan, Altohami, Mohammed, Tillet, Tania, Illingworth, Jack, Mukherjee, Leena, Apperly, Jane, Ashcroft, John, Rabin, Neil, Carmichael, Jonathan, Cazier, Jean‐Baptiste, Kerr, Rachel, Middleton, Gary, Collins, Graham P., Palles, Claire
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2021
Materias:
Covid‐19
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8652610/
https://www.ncbi.nlm.nih.gov/pubmed/34761389
http://dx.doi.org/10.1111/bjh.17937

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8652610/
https://www.ncbi.nlm.nih.gov/pubmed/34761389
http://dx.doi.org/10.1111/bjh.17937

Ejemplares similares